# Post-exposure prophylaxis clinical trials (Ituri)

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/post-exposure-prophylaxis-clinical-trials-ituri
Canonical HTML page: https://getbiobrief.com/entity/post-exposure-prophylaxis-clinical-trials-ituri

## Timeline

- **2026-08-04**: Leadership Visits and Latest Data Released — Africa CDC Director-General Jean Kaseya visited Bunia, WHO Director-General Tedros arrived in Kinshasa; government update reported 3,802 cases and 1,707 deaths.
- **2026-08-03**: Healthcare Workers Issue Ultimatum — In Mongbwalu, healthcare workers threatened to escalate action within 24 hours if unpaid wages were not resolved.
- **2026-06-15**: Uganda Declared Ebola‑Free — Neighboring Uganda discharged its last Ebola patient, ending its own transmission chain linked to the Congo outbreak.
- **2026-05-15**: Outbreak Declared — Eastern Congo Ebola outbreak officially declared, later linked to Bundibugyo virus.

## Recent coverage (1 stories)

### As Ebola Deaths Top 1,700, Biotech Races for Bundibugyo Virus Treatments
2026-08-04 15:58:13 · Sentiment: Strongly negative · Impact: 8/10 · Sources: 6

Congo’s Bundibugyo Ebola outbreak has surged to 3,802 cases and 1,707 deaths, highlighting an urgent need for vaccines and treatments. With no approved products available, two post‑exposure prophylaxis trials in Ituri and two vaccine trials in the UK and Canada are now underway, while nearly 80% of new cases elude contact tracing.
Full story: https://getbiobrief.com/story/ebola-deaths-top-1700-bundibugyo-virus-trials

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.